These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253 [Abstract] [Full Text] [Related]
6. In vitro activity of voriconazole against Candida species isolated in Taiwan. Yang YL, Cheng HH, Lo HJ. Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436 [Abstract] [Full Text] [Related]
9. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, Deku JG, Kasu ES, Mensah P, Agede CY, Dodoo C, Asiamah EA, Tampuori J, Korbuvi J, Opintan JA. BMC Pregnancy Childbirth; 2020 May 06; 20(1):266. PubMed ID: 32375724 [Abstract] [Full Text] [Related]
19. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. Anh DN, Hung DN, Tien TV, Dinh VN, Son VT, Luong NV, Van NT, Quynh NTN, Van Tuan N, Tuan LQ, Bac ND, Luc NK, Anh LT, Trung DM. BMC Infect Dis; 2021 Jun 03; 21(1):523. PubMed ID: 34082699 [Abstract] [Full Text] [Related]